Articles tagged "Public policy"

2019 American Transplant Congress
Determining the Role of Insurance Coverage at the Time of Renal Transplantation as a Predictor of Medication Misadventure
D. Wilkerson, P. Klem
Pharmacy, University of Colorado Skaggs School of Pharmacy, Aurora, CO
*Purpose: To determine if patients who receive financial assistance through the American Kidney Fund (AKF) for health care premiums at the time of transplant are…
2019 American Transplant Congress
OPO Aggressiveness Index: A Novel OPO Performance Metric That Incentivizes Pursuit of Marginal Deceased Donor Candidates
L. Liyanage, Y. Yu, K. Jackson, J. Garonzik-Wang, D. Segev, A. Massie
Johns Hopkins, Baltimore, MD
*Purpose: Of 2.5M deaths in the US every year, only 10,000 are recovered for transplantation; recovery of organs from older donors is rare although similar…
2019 American Transplant Congress
Sensitivity of 5-Tier System to Unadjusted Confounding
N. Salkowski, A. Wey, J. Snyder
SRTR, Minneapolis, MN
*Purpose: The Scientific Registry of Transplant Recipients (SRTR) fits risk-adjusted models for its semiannual program-specific reports (PSRs). Although SRTR adjusts for as many important risk…
2019 American Transplant Congress
Organ Procurement Organization Performance is Not Related to Educational Spending
J. P. Roberts¹, J. Bragg-Gresham², P. Held³
¹Univ of California-San Francisco, San Francisco, CA, ²Nephrology, University of Michigan, Ann Arbor, MI, ³Stanford University, Stanford, CA
*Purpose: We examined the educational spending by OPOs in relationship to OPO performance metrics.*Methods: Data sources: OPO Cost Reports (CMS 216-94 Form), SRTR OPO Specific…
2018 American Transplant Congress
Geographic Variation in the Treatment of Adult Heart Transplant Candidates in the US
W. Parker,¹ M. Churperk,¹ D. Hedeker,¹ E. Huang,¹ E. Garrity,¹ M. Siegler,¹ A. Anderson.²
¹University of Chicago, Chicago, IL; ²Northwestern University, Chicago, IL.
The current priority ranking system for US heart transplant candidates is based on treatment intensity which may encourage the overtreatment of relatively stable candidates. We…
2018 American Transplant Congress
The Kidney Allocation System from the Perspective of a Small Program in a Donor Service Area
K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² S. Hanna,² J. Africa.¹
¹Glickman Institute, Cleveland Clinic, Cleveland, OH; ²Urology and Renal Transplant, Charleston Area Medical Center, Charleston, WV.
This study investigated the impact of the new kidney allocation system (KAS) on a small transplant program (SP) when compared with the 3 other centers…
2018 American Transplant Congress
Effect of Kidney Allocation System on a Solitary, Isolated, Rural Transplant Program
K. Brown,² S. Hill,² L. Lipscomb,² A. Jones,² J. Africa.¹
¹Glickman Institute, Cleveland Clinic, Cleveland, OH; ²Urology and Renal Transplant, Charleston Area Medical Center, Charleston, WV.
The new kidney allocation system (KAS) was expected to create an impact on smaller, rural and geographically isolated centers.Methods. We examined the changes by the…
2018 American Transplant Congress
Geographic Variation in the Survival Benefit of Heart Transplantation
W. Parker,¹ R. Gibbons,¹ M. Churpek,¹ A. Anderson.²
¹University of Chicago, Chicago, IL; ²Northwestern University, Chicago, IL.
Purpose: Heart transplant candidate selection and treatment practices vary substantially across the US. We aimed to determine if transplant center practices modify the survival benefit…
2018 American Transplant Congress
Program-Specific Transplant Rate Ratios: Association with Allocation Priority at Listing and Posttransplant Outcomes
A. Wey, S. Gustafson, N. Salkowski, J. Pyke, B. Kasiske, A. Israni, J. Snyder.
SRTR, Mineapolis.
The Scientific Registry of Transplant Recipients (SRTR) has updated the transplant rate and waitlist mortality risk-adjustment models to include a wider range of candidate characteristics…
2018 American Transplant Congress
Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015
K. Ross,¹ R. Lynch,² D. Goldberg,³ R. Patzer.^1,2
¹Department of Epidemiology, Rollins School of Public Health, Atlanta, GA; ²Emory Transplant Center, Atlanta, GA; ³Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
Background: There are no population-based estimates of the prevalence of end-stage liver disease in the United States, creating challenges in measuring disease burden to inform…